Skip to main content
. 2016 Dec 5;2016:4213712. doi: 10.1155/2016/4213712

Table 1.

Demographic characteristics of the sepsis cohort.

Variables All sepsis Pulmonary-sepsis Abdominal-sepsis p a Nonsurvivors Survivors p b
n = 483 n = 272 n = 180 n = 219 n = 216
Age, mean (SD) 60.3 (16.2) 63.7 (15.3) 56.7 (16.1) 0.000∗∗ 64.2 (15.3) 56.7 (16.6) 0.000∗∗
Male sex, n% 319 (66.0) 186 (67.6) 114 (63.3) 0.363 140 (64.2) 147 (68.1) 0.418
APACHE II, mean (SD) 21.5 (7.9) 23.0 (6.9) 18.6 (8.0) 0.000∗∗ 24.4 (7.5) 19.3 (7.4) 0.000∗∗
SOFA 8 (6–11) 9 (7–12) 7 (5–11) 0.003∗∗ 10 (7–12) 7 (5–10) 0.000∗∗
SOFA, nonpulmonary 6 (4–8) 6 (4–8) 5 (3–8) 0.125 7 (5–9) 5 (3–8) 0.000∗∗
Charlson Comorbidity Index 3 (1–5) 4 (2–5) 2 (1–4) 0.000∗∗ 4 (2–5) 2 (1–4) 0.000∗∗
Comorbidities
 Cardiovascular disease 182 (37.7) 121 (44.5) 51 (28.3) 0.001∗∗ 98 (45.0) 76 (35.2) 0.040
 Cerebrovascular disease 47 (9.7) 35 (12.9) 9 (5.0) 0.006∗∗ 25 (11.5) 19 (8.8) 0.427
 Diabetes mellitus 88 (18.2) 55 (20.2) 25 (13.9) 0.102 47 (21.6) 36 (16.7) 0.223
 Peripheral vascular disease 65 (13.5) 46 (16.9) 18 (10.0) 0.040 29 (13.3) 30 (13.9) 0.889
 Digestive and liver disease 140 (29.0) 70 (25.7) 66 (36.7) 0.016 68 (31.2) 61 (28.2) 0.529
 Malignancy 71 (14.7) 41 (15.1) 26 (14.4) 0.893 41 (18.8) 25 (11.6) 0.045
 Chronic pulmonary disease 110 (22.8) 87 (32.0) 21 (11.7) 0.000∗∗ 64 (29.4) 36 (16.7) 0.002∗∗
 Chronic kidney disease 40 (8.3) 31 (11.4) 7 (3.9) 0.005∗∗ 22 (10.1) 16 (7.4) 0.396
 Other diseases 110 (22.8) 76 (27.9) 30 (16.7) 0.006∗∗ 58 (26.6) 40 (20.4) 0.141
Pathogen, n%
 Gram positive 40 (8.3) 19 (7.0) 16 (8.9) 0.591 12 (5.6) 16 (7.6) 0.439
 Gram negative 265 (54.9) 152 (55.9) 97 (53.9) 0.495 121 (56.3) 111 (52.6) 0.496
 Fungus 175 (36.2) 122 (44.9) 42 (23.3) 0.000∗∗ 98 (45.0) 60 (27.8) 0.000∗∗
 Virus 20 (4.1) 16 (5.9) 3 (1.7) 0.031 7 (3.2) 9 (4.2) 0.621
Type of sepsis, n% 0.084 0.000∗∗
 Sepsis 37 (7.7) 23 (8.5) 11 (6.1) 0.467 5 (2.3) 23 (10.6) 0.000∗∗
 Severe sepsis 133 (27.5) 83 (30.5) 44 (24.4) 0.166 50 (22.9) 72 (33.3) 0.019
 Septic shock 313 (64.8) 166 (61.0) 125 (69.4) 0.072 163 (74.8) 121 (56.0) 0.000∗∗
Origin of sepsis, n%
 Pulmonary 272 (56.3) 152 (69.7) 100 (46.3) 0.000∗∗
 Abdominal 180 (37.3) 50 (22.9) 102 (47.2) 0.000∗∗
 Other 31 (6.4) 16 (7.3) 15 (6.9) 1.000
Pulmonary infectionc, n% 346 (71.6) 272 (100) 62 (34.4) 0.000∗∗ 172 (78.9) 135 (62.5) 0.000∗∗
ICU treatment within 24 h hours, n%
 IPPV 420 (87.0) 228 (83.8) 164 (91.1) 0.033 195 (90.3) 180 (88.7) 0.634
 NPPV 34 (7.0) 24 (8.8) 8 (4.4) 0.092 15 (6.9) 16 (7.9) 0.852
 Tracheal extubationd 40 (8.3) 8 (2.9) 30 (16.9) 0.000∗∗ 12 (5.5) 26 (12.0) 0.017
 Vasopressor 181 (37.5) 91 (33.5) 74 (41.7) 0.090 103 (47.2) 64 (29.6) 0.000∗∗
ARF, n% 74 (15.3) 48 (17.6) 19 (10.6) 0.043 54 (24.8) 17 (7.9) 0.000∗∗
CRRT, n% 83 (17.2) 55 (20.2) 20 (11.1) 0.014 60 (27.5) 21 (9.7) 0.000∗∗
MV, d 8 (3–16) 11 (5–20.8) 5 (2–11) 0.000∗∗ 11 (4–21) 6 (3–13) 0.000∗∗
ICU LOS, d 13 (6–23) 14 (7–3) 8.5 (4–19) 0.000∗∗ 14 (5–24) 12 (6–22) 0.605
Hospital LOS, d 23 (13–39) 24 (13–37) 23 (13–44) 0.649 18 (8.8–33) 28 (17–47) 0.000∗∗
ICU mortality 86 (17.8) 61 (22.4) 16 (8.9) 0.000∗∗
Hospital mortality 97 (20.1) 68 (25.0) 18 (10.0) 0.000∗∗
28-day mortalitye 79 (23.4) 58 (31.7) 17 (12.6) 0.000∗∗
1-year mortalityf 122 (36.1) 83 (45.4) 33 (24.4) 0.000∗∗
Laboratory parameters on admission
 PLT 109 140 (88–219) 137 (85–200) 158 (89–248) 0.041 133 (72–203) 152 (92–232) 0.027
 Albumin g/L, mean (SD) 26.9 (6.8) 29.1 (6.1) 23.4 (6.7) 0.000∗∗ 27.5 (23.3–31.6) 26.6 (21.7–31.1) 0.071
 Creatinine, μmol/L 82 (57–142) 84 (59–171) 79 (54–125) 0.072 98 (61–197) 73 (54–119) 0.001∗∗
 Cystatin c, mg/L 1.1 (0.9–1.9) 1.3 (0.9–2.2) 0.9 (0.7–1.4) 0.000∗∗ 1.4 (1.0–2.3) 1.0 (0.8–1.4) 0.000∗∗
 LDH IU/L 272 (198–435) 304 (232–476) 217 (164–328) 0.000∗∗ 305 (230–487) 242 (180–375) 0.000∗∗
 Anion gap, mmol/L 17.4 (14.5–21.0) 17.0 (14.2–21.3) 18.2 (15.6–20.6) 0.129 17.9 (14.5–22.1) 17.3 (14.4–20.2) 0.012
 Lactateg, mmol/L 1.9 (1.3–3.1) 1.8 (1.3–2.5) 1.9 (1.4–3.6) 0.033 1.9 (1.4–3.3) 1.8 (1.3–3.1) 0.239
 PaO2/FiO2,mmHg 189.0 (121.8–263.3) 170.5 (109.4–229.9) 208.5 (146.6–294.0) 0.000∗∗ 169.2 (100.6–238.6) 204 (150.0–277.3) 0.000∗∗
 PaO2,mmHg 85 (70–119) 80 (68–109) 97 (77–135) 0.000∗∗ 81 (67–115) 87 (73–131) 0.055

Quantitative data was presented as median (IQR), and qualitative data was presented as n (%) except otherwise indicated. SD, standard deviation; IPPV, invasive ventilation; NPPV, noninvasive ventilation; ARF, acute renal failure; CRRT, continuous renal replacement therapy; MV, mechanical ventilation; ICU LOS, length of ICU stay; hospital LOS, length of hospital stay; PLT, platelet; LDH, lactate dehydrogenase.

aComparison between pulmonary-sepsis and abdominal-sepsis.

bComparison between one-year survivors and nonsurvivors.

cPulmonary infection was defined as pulmonary infection identified during the whole ICU stay period.

dWhen analyzing the ratio of extubation in the first 24 h of ICU administration, patients without mechanical ventilation were excluded.

e, fPatients who died in ICU or lost to follow-up were excluded. There was a total of 338 sepsis patients, 183 of them had pulmonary-sepsis, and 135 had abdominal-sepsis when analyzing 28-day or one-year mortality.

gThere was a total of 290 sepsis patients with measurement of lactate within the first 24 h; of those 155 had pulmonary-sepsis and 114 had abdominal-sepsis.

p < 0.05.  ∗∗ p < 0.01.